1. Home
  2. INUV vs LPCN Comparison

INUV vs LPCN Comparison

Compare INUV & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$2.56

Market Cap

52.5M

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$5.13

Market Cap

13.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
LPCN
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.5M
13.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
INUV
LPCN
Price
$2.56
$5.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.00
$7.00
AVG Volume (30 Days)
109.0K
66.7K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,139,861.00
$4,322,693.00
Revenue This Year
$20.86
N/A
Revenue Next Year
$14.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.11
N/A
52 Week Low
$2.34
$2.52
52 Week High
$7.90
$5.50

Technical Indicators

Market Signals
Indicator
INUV
LPCN
Relative Strength Index (RSI) 40.88 88.19
Support Level $2.50 $4.07
Resistance Level $2.77 $3.39
Average True Range (ATR) 0.17 0.33
MACD -0.02 0.18
Stochastic Oscillator 11.65 99.09

Price Performance

Historical Comparison
INUV
LPCN

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: